RBC Capital Markets adjusted its stance on Intra-Cellular Therapies shares, downgrading the biopharmaceutical company from Outperform to Sector Perform. The firm, however, raised its price target on ...

Infinity Natural Resources, Inc. (“Infinity”) announced today the launch of its initial public offering of 13,250,000 shares of Class A common stock, ...

RBC Capital Markets analysts raised the price target for Webster Financial Corporation, traded on the New York Stock Exchange ...

Financial-services firm RBC downgraded CF Industries from Outperform to Sector Perform, citing fair valuation and potential ...

RBC Capital analyst Gerard Cassidy maintained a Buy rating on Regions Financial (RF – Research Report) on January 17 and set a price target of ...

Following almost ten years at ING bank, market structure expert Stephane Malrait joined Etrading Software as chair of its ...

In a report released on January 16, Gerard Cassidy from RBC Capital maintained a Buy rating on PNC Financial (PNC – Research Report), with a ...

Critchley’s departure coincided with that of Dave Thomas, who retired as CEO of RBC Capital Markets Europe at the end of the ...

Ballet Hispánico will present Gustavo Ramírez Sansano's masterwork CARMEN.maquia at New York City Center from May 29-June 1, ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...